Asiri Surgical Hospital PLC
Asiri Surgical Hospital PLC operates in the healthcare facilities and services industry, providing surgical and related medical services to patients in Sri Lanka.
Business. Asiri Surgical Hospital PLC (AMSL.CM) operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Sri Lanka and is listed on the Colombo Stock Exchange under the ticker AMSL.CM. Specific details regarding operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Asiri Surgical Hospital PLC (AMSL.CM) operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Sri Lanka and is listed on the Colombo Stock Exchange under the ticker AMSL.CM. Specific details regarding operating segments and geographic revenue mix are not available.
Asiri Surgical Hospital PLC maintains a debt-to-equity ratio of 0.5, indicating a balanced capital structure with moderate leverage. The company's liquidity position is characterized as medium, with a current ratio of 1.5, suggesting it can cover short-term obligations but with limited buffer. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
Profitability metrics show a return on equity (ROE) of 2.26% and a return on assets (ROA) of 1.08%, both below the industry median for healthcare facilities and services. These figures suggest the company is underperforming in terms of capital efficiency and asset utilization.
The company's revenue is concentrated in a single geographic market, Sri Lanka, with no disclosed international operations. This geographic concentration increases exposure to local economic and regulatory risks. No segment-specific revenue breakdown is available, limiting visibility into the performance of different service lines.
Looking ahead, the company's revenue is expected to grow, though the exact rate is not disclosed. Historical revenue of LKR 1.7 billion provides a baseline for future performance. The company's free cash flow of LKR 242.99 million indicates some capacity for reinvestment or shareholder returns, though capital expenditures of LKR 39.81 million suggest ongoing investment in infrastructure.
The company's risk profile is marked by medium liquidity risk and low dilution potential. The negative net cash position after debt is a key flag, but the absence of recent dilutive events and a stable share count suggest no immediate pressure on equity. No recent filings or transcripts are available to provide additional context on strategic or operational developments.
- Asiri Surgical Hospital PLC maintains a balanced capital structure with a debt-to-equity ratio of 0.5.
- The company's ROE and ROA are below industry medians, indicating suboptimal capital and asset efficiency.
- Revenue is concentrated in Sri Lanka, increasing exposure to local economic and regulatory risks.
- Free cash flow of LKR 242.99 million provides some flexibility for reinvestment or shareholder returns.
- The company's liquidity position is medium, with a current ratio of 1.5 and a negative net cash position after debt.
Bull / Bear case
Generated · model-assistedNet income surged 209.7% year-over-year to LKR 822.9 million, demonstrating strong recent profitability recovery.
Free cash flow increased 114.1% year-over-year to LKR 857.6 million, highlighting improved cash generation capabilities.
Revenue grew 7.5% year-over-year to LKR 7.72 billion, showing consistent top-line expansion in the latest period.
Debt-to-equity ratio of 0.5 is below the cohort median of 0.32, suggesting a conservative leverage position.
Cash conversion ratio of -1.29 ranks in the bottom quartile, signaling poor cash flow quality relative to earnings.
The company faces high credit risk, posing significant potential challenges to financial stability and borrowing costs.
Net income CAGR of -8.7% over four years reveals long-term earnings volatility despite recent growth.
Medium liquidity risk flags potential difficulties in meeting short-term financial obligations or operational needs.
In focus — financials by report
Revenue LKR 6.62B, +17,5% YoY; Operating income −51,5% YoY.
- ▍Revenue LKR 6.62B, +17,5% YoY
- ▍Operating income −51,5% YoY
- ▍Net income −94,3% YoY
- ▍Free cash flow +102,2% YoY
- ▍Net margin 0.5%
Revenue LKR 5.63B, −3,5% YoY; Operating income −31,5% YoY.
- ▍Revenue LKR 5.63B, −3,5% YoY
- ▍Operating income −31,5% YoY
- ▍Net income −53,1% YoY
- ▍Free cash flow −71,2% YoY
- ▍Net margin 9.9%
Revenue LKR 5.84B; Operating income LKR 1.46B.
- ▍Revenue LKR 5.84B
- ▍Operating income LKR 1.46B
- ▍Net margin 20.3%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Asiri Surgical Hospital PLC Market data — financials · 2026-05-27